DE60230194D1 - Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicycloä2.2.1ühept-1-ylmethanesulphonamide-familie - Google Patents

Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicycloä2.2.1ühept-1-ylmethanesulphonamide-familie

Info

Publication number
DE60230194D1
DE60230194D1 DE60230194T DE60230194T DE60230194D1 DE 60230194 D1 DE60230194 D1 DE 60230194D1 DE 60230194 T DE60230194 T DE 60230194T DE 60230194 T DE60230194 T DE 60230194T DE 60230194 D1 DE60230194 D1 DE 60230194D1
Authority
DE
Germany
Prior art keywords
family
ylmethanesulphonamide
dicylcohexyl
hydroxy
members
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60230194T
Other languages
English (en)
Inventor
Javier Llompart
Jorge Galvez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medisyn Technologies Inc
Original Assignee
Medisyn Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medisyn Technologies Inc filed Critical Medisyn Technologies Inc
Application granted granted Critical
Publication of DE60230194D1 publication Critical patent/DE60230194D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60230194T 2002-09-20 2002-09-20 Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicycloä2.2.1ühept-1-ylmethanesulphonamide-familie Expired - Lifetime DE60230194D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2002/029951 WO2004026225A2 (en) 2002-09-20 2002-09-20 Therapeutic agents and corresponding treatments
US10/251,616 US6919376B2 (en) 2002-09-20 2002-09-20 Therapeutic agents and corresponding treatments

Publications (1)

Publication Number Publication Date
DE60230194D1 true DE60230194D1 (de) 2009-01-15

Family

ID=31992784

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60230194T Expired - Lifetime DE60230194D1 (de) 2002-09-20 2002-09-20 Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicycloä2.2.1ühept-1-ylmethanesulphonamide-familie

Country Status (8)

Country Link
US (1) US6919376B2 (de)
EP (1) EP1560573B1 (de)
JP (1) JP4469720B2 (de)
AT (1) ATE415961T1 (de)
AU (1) AU2002357644A1 (de)
CA (1) CA2499523C (de)
DE (1) DE60230194D1 (de)
WO (1) WO2004026225A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266732A1 (en) * 2002-09-20 2004-12-30 Jorge Galvez Therapeutic agents, methods, and treatments
JP5049124B2 (ja) * 2004-07-09 2012-10-17 メディスィン テクノロジーズ， インコーポレイテッド 治療化合物および処置
JP5007226B2 (ja) 2004-07-15 2012-08-22 エーエムアール テクノロジー インコーポレイテッド アリールおよびヘテロアリール置換テトラヒドロイソキノリンならびにノルエピネフリン、ドーパミン、およびセロトニンの再取り込みを遮断するためのその利用方法
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
KR101830447B1 (ko) * 2009-05-12 2018-02-20 알바니 몰레큘라 리써치, 인크. 7-(［1,2,4］트리아졸로［1,5-α］피리딘-6-일)-4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로이소퀴놀린 및 이의 용도
JP5739415B2 (ja) * 2009-05-12 2015-06-24 ブリストル−マイヤーズ スクウィブ カンパニー （Ｓ）−７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンの結晶形態およびその使用
CN102458123A (zh) * 2009-05-12 2012-05-16 阿尔巴尼分子研究公司 芳基、杂芳基和杂环取代的四氢异喹啉及其用途
WO2011140296A1 (en) 2010-05-05 2011-11-10 Infinity Pharmaceuticals Triazoles as inhibitors of fatty acid synthase
EP3159331A1 (de) 2010-05-05 2017-04-26 Infinity Pharmaceuticals, Inc. Tetrazolone als fettsäuresynthasehemmer
WO2015017798A2 (en) 2013-08-02 2015-02-05 CRIXlabs, Inc. Method and system for predicting spatial and temporal distributions of therapeutic substance carriers
JO3637B1 (ar) 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗ｒｓｖ活性之吡唑并嘧啶
EA202091835A1 (ru) 2018-01-31 2020-10-20 Янссен Сайенсиз Айрлэнд Анлимитед Компани Замещенные циклоалкилом пиразолопиримидины, обладающие активностью против rsv
ES2957316T3 (es) 2018-04-23 2024-01-17 Janssen Sciences Ireland Unlimited Co Compuestos heteroaromáticos que tienen actividad contra VSR

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2295616A (en) * 1994-12-01 1996-06-05 Zeneca Ltd N-Diazine-benzenesulphonamide derivatives as endothelin receptor antagonists
WO2000000207A1 (en) 1998-06-29 2000-01-06 Children's Hospital Of Los Angeles Treatment of hyperproliferative disorders
US6576613B1 (en) * 1998-07-24 2003-06-10 Corvas International, Inc. Title inhibitors of urokinase
US6290929B1 (en) 2000-07-28 2001-09-18 The Procter & Gamble Company Cancer treatment

Also Published As

Publication number Publication date
AU2002357644A1 (en) 2004-04-08
US20040059000A1 (en) 2004-03-25
ATE415961T1 (de) 2008-12-15
CA2499523A1 (en) 2004-04-01
JP4469720B2 (ja) 2010-05-26
EP1560573B1 (de) 2008-12-03
EP1560573A2 (de) 2005-08-10
AU2002357644A8 (en) 2004-04-08
JP2006503058A (ja) 2006-01-26
EP1560573A4 (de) 2006-07-19
CA2499523C (en) 2011-04-19
WO2004026225A3 (en) 2004-07-22
US6919376B2 (en) 2005-07-19
WO2004026225A2 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
DE60230194D1 (de) Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicycloä2.2.1ühept-1-ylmethanesulphonamide-familie
ATE461217T1 (de) Glp-1-verbindungen
DE602004012083D1 (de) Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren
NO20052928L (no) Nye kjemiske forbindelser
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
MXPA05005107A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
DE602005026105D1 (de) Verwendung von agonisten und antagonisten von interleukin-33 (il-33)
ATE320435T1 (de) Oxazolo-, thiazolo- und selenazolo-(4,5- c)naphthyridin-4-amine und analoge davon
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
AU5338301A (en) Methods and compositions for modulating alpha adrenergic receptor activity
SE0301653D0 (sv) Novel compounds
DK1104425T3 (da) Hidtil ukendte thiazolopyrimidinforbindelser
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
NO20052267L (no) Forbindelser, Preparater og Metoder
EA200400235A1 (ru) Комбинированная терапия для лечения рака
DK0944616T3 (da) Bicykliske arylcarboxamider og deres terapeutiske anvendelse
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
AU8497701A (en) Claudin polypeptides
ATE411984T1 (de) Neue kondensierte n-pyrazinyl-sulfonamide und deren verwendung bei der behandlung von chemokinvermittelten krankheiten
ATE447426T1 (de) Elektromagnetische stimulation bei patienten mit osteoporose
ATE433458T1 (de) Modulatoren von ship-1
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
ATE383874T1 (de) Perylenequinonen zur anwendung als sonosensitizer
NO20045343L (no) Ny kombinasjon for behandling av luftveisforstyrrelser

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: MAHLER, P., DIPL.-PHYS., PAT.-ANW., 22397 HAMBURG

8364 No opposition during term of opposition